RARE Intrinsic Valuation and Fundamental Analysis - Ultragenyx Pharmaceutical Inc

	Ultragenyx Pharmaceutical Inc NASDAQ:RARE	US
P	Procter & Gamble Co XBER:PRG	US
N	National Storage Affiliates Trust F:4GC	US

Intrinsic Value

The intrinsic value for Ultragenyx Pharmaceutical Inc (RARE) under the Base Case is 34.97 USD. Compared with the current market price of 25.57 USD, the stock appears Undervalued by 27% .

Intrinsic value calculated using Multiples

$34.97

Other reference points

DCF valuation

$43.72

Wall St target

$53.1

Do our valuations actually work? See backtest results .

RARE Intrinsic Value

Undervaluation 27%

Intrinsic Value

Price $25.57

Track Buy Zone

20% below Intrinsic Value $27.97

Get notified when the price drops into your buy zone

Intrinsic Value $34.97

Margin of Safety 20% $27.97

Current Price $25.57

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Ultragenyx Pharmaceutical Inc.

Explain Valuation